Observational Study to Investigate the Long-term Effects of MIRCERA in Clinical Routine

Roche

Status: Completed

Conditions: Anemia

Study type: Observational

Funder types: Industry

Identifiers

NCT01309269

ML22911

Details and patient eligibility

About

This observational study will assess the effect of long-term treatment with Mircera (methoxy polyethylene glycol-epoetin beta) in chronic kidney disease patients with renal anemia. Data will be collected from each patient for at least 24 months.

Enrollment: 1,083 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients, >/= 18 years of age
• Patients with chronic kidney disease (CKD), stages IV and V
• Treatment with Mircera according to label

Exclusion criteria

• Pregnant or breastfeeding women

Trial design

1,083 participants in 1 patient group

Cohort